Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myozyme in Advanced Late-onset Pompe Disease
NCT00268944Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Mar 2007
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT00268944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268944.